Stifel Financial
MDGL icon

Stifel Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Stifel Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
2,336
-5
-0.2% -$2.56K ﹤0.01% 2405
2026
Q1 		$1.23M Buy
2,341
+14
+0.6% +$6.69K ﹤0.01% 2310
2025
Q4 		$1.36M Sell
2,327
-282
-11% -$144K ﹤0.01% 2237
2025
Q3 		$1.2M Sell
2,609
-565
-18% -$211K ﹤0.01% 2278
2025
Q2 		$961K Buy
3,174
+77
+2% +$22.9K ﹤0.01% 2359
2025
Q1 		$1.03M Buy
3,097
+499
+19% +$164K ﹤0.01% 2214
2024
Q4 		$802K Sell
2,598
-107
-4% -$30.1K ﹤0.01% 2394
2024
Q3 		$574K Sell
2,705
-263
-9% -$67.3K ﹤0.01% 2590
2024
Q2 		$832K Buy
+2,968
New +$707K ﹤0.01% 2296

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stifel Financial's MDGL Position: Q2 2026 in Review

Stifel Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 0.21% in Q2 2026, selling an estimated $2.56K and leaving 2,336 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Stifel Financial first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.36M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Stifel Financial held 2,336 shares of Madrigal Pharmaceuticals worth $1.25M as of Q2 2026.
  • Stifel Financial sold 5 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.56K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2405 holding.
  • Stifel Financial first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Stifel Financial's Madrigal Pharmaceuticals position peaked at $1.36M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.